Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.100 |
None |
0.930 |
43 |
|
2003 |
2019 |
HIV-1 infection
|
disease |
|
Disease or Syndrome
|
695
|
94
|
0.100 |
None |
0.963 |
27 |
5
|
2004 |
2019 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.100 |
None |
1.000 |
19 |
|
2005 |
2019 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Complete atrioventricular block
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
403
|
96
|
0.020 |
None |
1.000 |
2 |
1
|
2010 |
2019 |
Cervical Intraepithelial Neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
398
|
29
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Superinfection
|
group |
Infections
|
Disease or Syndrome
|
85
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
hiv-infection/aids
|
disease |
Infections
|
Disease or Syndrome
|
124
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Measles
|
disease |
Infections
|
Disease or Syndrome
|
113
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Human papilloma virus infection
|
disease |
Infections
|
Disease or Syndrome
|
429
|
42
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Malignant tumor of cervix
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1718
|
245
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cervix Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
43
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Immunologic Deficiency Syndromes
|
group |
Immune System Diseases
|
Disease or Syndrome
|
973
|
31
|
0.040 |
None |
1.000 |
4 |
1
|
2005 |
2018 |
HIV disease progression
|
disease |
|
Disease or Syndrome
|
54
|
5
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2018 |
Cytomegalovirus Infections
|
group |
Infections
|
Disease or Syndrome
|
462
|
26
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Enterovirus Infections
|
group |
Infections
|
Disease or Syndrome
|
237
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.090 |
None |
1.000 |
9 |
|
2004 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2017 |
Carcinoma in situ of uterine cervix
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
18
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |